Pharmaceutical Industry
C-Suite‘We’ll save the world from cancer’: Inside Pfizer CEO’s $23 billion post‑COVID bet on oncology
By Nick LichtenbergJanuary 30, 2026
HealthAs billionaires chase immortality, this startup cofounded by a Harvard genetics professor gets FDA approval for the first partial de-aging human trial
By Marco Quiroz-GutierrezJanuary 30, 2026
Workplace CultureWalmart doubles down on health, promoting 3,000 pharmacy workers and upping earning potential—with no college degree required
By Sydney LakeJanuary 29, 2026
C-SuitePfizer CEO on how he struck a deal with President Trump in 10 days to lower American drug costs
By Fortune EditorsJanuary 27, 2026
InvestingInside Big Pharma and VC’s big bet on AI: You wouldn’t ‘want to fly an airplane designed by hand, but all of our drugs are designed like that’
By Nick LichtenbergJanuary 23, 2026
AIAI drug startup Insilico Medicine launches an AI ‘gym’ to help models like GPT and Qwen be good at science
By Nicholas GordonJanuary 22, 2026
EconomyTrump says Europe does one thing right: drug prices. ‘A pill that costs $10 in London costs $130 in New York or Los Angeles’
By Sasha RogelbergJanuary 21, 2026
AIAnthropic unveils Claude for Healthcare, expands life science features, and partners with HealthEx to let users connect medical records
By Jeremy KahnJanuary 11, 2026
EconomyMark Cuban on the $38 trillion national debt and the absurdity of U.S. healthcare: we wouldn’t pay for potato chips like this
By Nick LichtenbergJanuary 6, 2026
HealthGLP-1s could end up being ‘the first true longevity drug’ as the world battles a rising obesity crisis
By Angelica AngNovember 21, 2025
NewslettersWhy big pharma is teaming up with AI giants to speed up drug discovery and make work easier for health care workers
By John KellNovember 19, 2025
EconomyNovo Nordisk CFO outlines ‘ultimate defense’ against stock downgrades and lawsuits to retain weight-loss crown
By Eleanor PringleNovember 6, 2025
By Ted Kitterman and Great Place To WorkOctober 9, 2025
Most Popular
